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Abstract Purpose: To provide
clinicians practicing in resource-lim-
ited settings with a framework to
improve the diagnosis and treatment
of pediatric and adult patients with
sepsis. Methods: The medical liter-
ature on sepsis management was
reviewed. Specific attention was paid
to identify clinical evidence on sepsis
management from resource-limited
settings. Results: Recommendations
are grouped into acute and post-acute
interventions. Acute interventions
include liberal fluid resuscitation to
achieve adequate tissue perfusion,
normal heart rate and arterial blood
pressure, use of epinephrine or dopa-
mine for inadequate tissue perfusion
despite fluid resuscitation, frequent
measurement of arterial blood pres-
sure in hemodynamically unstable
patients, administration of hydrocor-
tisone or prednisolone to patients
requiring catecholamines, oxygen
administration to achieve an oxygen
saturation [90%, semi-recumbent
and/or lateral position, non-invasive
ventilation for increased work of
breathing or hypoxemia despite oxy-
gen therapy, timely administration of
adequate antimicrobials, thorough
clinical investigation for infectious
source identification, fluid/tissue
sampling and microbiological work-
up, removal, drainage or debridement
of the infectious source. Post-acute
interventions include regular re-
assessment of antimicrobial therapy,
administration of antimicrobials for
an adequate but not prolonged dura-
tion, avoidance of hypoglycemia,
pharmacological or mechanical deep
vein thrombosis prophylaxis,
resumption of oral food intake after
resuscitation and regaining of con-
sciousness, careful use of opioids and
sedatives, early mobilization, and
active weaning of invasive support.
Specific considerations for malaria,
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puerperal sepsis and HIV/AIDS
patients with sepsis are included.
Conclusion: Only scarce evidence
exists for the management of pediat-
ric and adult sepsis in resource-
limited settings. The presented
recommendations may help to
improve sepsis management in mid-
dle- and low-income countries.






Infection and sepsis are among the leading causes of
death worldwide. The annual burden of sepsis in high-
income countries is estimated to approach 2.8 million
cases with a mortality of *40% [1]. Despite these figures
from industrialized countries, the largest part of the global
sepsis burden occurs in middle- and low-income coun-
tries. Ninety percent of the worldwide deaths from
pneumonia, meningitis or other infections occur in less
developed countries [2]. Around 70% of the 9 million
global deaths in neonates and infants are attributable to
sepsis, with the majority of cases occurring in Asia and
sub-Saharan Africa [3]. A high incidence of bacterial,
parasitic and HIV infection combined with low hygienic
standards and vaccination rates, widespread malnutrition
and lack of resources, explain the disproportionally
high morbidity and mortality from sepsis in these coun-
tries [4, 5].
In 2004 and 2008, the Surviving Sepsis Campaign
released guidelines for severe sepsis and septic shock
management [6, 7]. Implementation of these guidelines
together with timely administration of essential therapies
(e.g., fluid resuscitation, antibiotics, source control mea-
sures) improved management and outcome [8, 9]. Similar
initiatives have been undertaken in children resulting in
comparable improvements in outcome [10, 11]. Despite
their benefits, the Surviving Sepsis Campaign and the
American College of Critical Care Medicine pediatric
guidelines cannot be implemented in most middle- or
low-income countries due to lacking resources [12–15].
This leaves those clinicians caring for the majority of
sepsis patients worldwide without standardized and
adoptable guidance for sepsis care.
The purpose of these recommendations is to provide
clinicians practicing in resource-limited settings with a
framework to improve the management of pediatric and
adult septic patients. The recommendations are specif-
ically based on resources affordable and commonly
available in middle- and low-income countries and
systematically weigh the available scientific evidence
for its applicability in resource-limited settings. They
are not meant to replace the Surviving Sepsis Campaign
[6, 7] or American College of Critical Care Medicine
pediatric guidelines [10, 11] but can be considered if
the latter are impossible to implement due to resource
constraints.
Methods
These recommendations were developed by the Global
Intensive Care working group of the European Society of
Intensive Care Medicine and the World Federation of
Pediatric Intensive and Critical Care Societies. The
working group consists of critical care physicians and
nurses from high-, middle- and low-income countries
aiming to improve intensive care in resource-limited
areas. Their members have extensive experience in caring
for critically ill patients in resource-limited settings. No
external funding was used. None of the authors had a
financial conflict of interest in regards to drugs or tech-
niques discussed in the manuscript or received honoraria
for any role while establishing the recommendations.
Plans and methods to develop the recommendations
were conceptualized in summer 2010. The group met at
the 23rd ESICM Congress in Barcelona/Spain, and the
31st ISICEM in Brussels/Belgium. In between, face-to-
face meetings, teleconferences and electronic-based dis-
cussions among group members were held to improve the
recommendations. Any disagreement was resolved by
further discussion and consensus, whenever possible.
Voting results of the expert panel on individual recom-
mendations are presented in the Electronic Supplementary
Material.
To identify the contemporary scientific evidence for
sepsis management, a structured literature review was
conducted using pre-defined terms (see Electronic Sup-
plementary Material for further details on the search
process). Furthermore, reference lists of identified arti-
cles, the latest sepsis guidelines, textbooks and personal
libraries were reviewed. Specific attention was paid to
identify clinical evidence on sepsis management origi-
nating from resource-limited settings. Based on survey
data on the availability of resources to implement the
Surviving Sepsis Campaign guidelines and American
College of Critical Care Medicine pediatric guidelines in
middle- and low-income countries [12–15], scientific
evidence was adjusted to resource-limited settings. In
addition, expert opinion and clinical experience of the
authors in providing sepsis care in middle- and low-
income countries was considered. The level of scientific
evidence (LoE) of each recommendation was classified as
high (LoE: A; supported by the results of randomized,
controlled trials or meta-analyses), moderate (LoE: B;
supported by the results of low-quality randomized
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controlled trials or high-quality observational studies),
low (LoE: C; supported by the results of observational
studies) or very low (LoE: D; supported by the results of
case series or the opinion of experts). Since extrapolation
of evidence from well-resourced to resource-limited
countries is problematic given fundamental differences in
sepsis epidemiology [2, 4], the educational level of health
care providers [15, 16], health care facilities and resources
[12–15], the level of evidence attributed to some recom-
mendations differs from recommendations published by
others [6, 7, 10].
Recognizing the septic patient
Recognizing the patient with sepsis is an essential step
for effective treatment. Given the widespread lack of
facilities to diagnose sepsis according to international
definitions in resource-limited settings, modified defini-
tions of sepsis, severe sepsis and septic shock, which can
be applied also with limited resources, are summarized in
Table 1. More details on how to recognize the patient
with sepsis in resource-limited settings are given in the
Electronic Supplementary Material.
Treating the septic patient
General considerations
General considerations regarding the treatment of patients
with sepsis are summarized in Table 2. More details are
presented in the Electronic Supplementary Material.
Acute interventions
Acute interventions (Table 3) refer to treatments recom-
mended to be administered without delay. Although acute
interventions are presented and suggested in this manu-
script in a certain order (Fig. 1), some interventions could
and should be performed simultaneously, depending on
the condition of the patient.
Circulation
1. Use adequate tissue perfusion as the principal endpoint
of resuscitation (LoE: A). In addition, target a systolic
arterial blood pressure[90 mmHg in adults, as well as
normal heart rate and arterial blood pressure in chil-
dren (LoE: D).
Background Given that tissue hypoperfusion is a key
factor contributing to sepsis-associated organ failure [17],
one principal goal of resuscitation is to promptly restore
tissue perfusion [6, 7]. Although adequate tissue perfusion
is often associated with a systolic arterial blood pressure
[90 mmHg, some patients may restore tissue perfusion
with lower arterial pressures. On the other hand,
achievement of a normal arterial blood pressure is not
necessarily associated with adequate tissue perfusion [18].
Therefore, arterial blood pressure alone is not a reliable
endpoint for assessing adequacy of tissue perfusion.
Although no clinical parameter exists to directly assess
adequacy of tissue perfusion, clinical variables presented
in Table 4 may be used [19]. Clinical signs of dehydration
(e.g., dry mucous membranes, skin tenting) are rare in
acute sepsis and should make the clinician consider a sub-
acute or chronic disease process with superimposed
infection.
2. In patients with tissue hypoperfusion, infuse fluids
aggressively and continue liberal infusions for 24–48 h
(LoE: C). More than 4 L during the first 24 h may be
required to adequately resuscitate the adult septic
patient.
Background Despite the development of interstitial
edema, hypovolemia arising from true fluid loss or cap-
illary leakage with interstitial edema formation is a main
cause of tissue hypoperfusion in sepsis [20]. Fluid therapy
increases systemic blood flow and oxygen delivery [21].
Aggressive fluid resuscitation reduced mortality in
patients with typhoid ileal perforation in rural Africa [22].
In Ugandan patients with Gram negative bacteremia,
mortality was decreased in patients receiving [1 L of
fluid compared to those receiving less or no fluids [23].
Children with septic shock receiving\20 mL/kg of fluids
had twice as high mortality compared to children
receiving [40 mL/kg of fluids during the first hour [24].
Fluid resuscitation is of particular importance in children
with the Dengue shock syndrome, a clinical scenario
characterized by vascular leakage and hypovolemia [25,
26].
A recent study by Maitland et al. [27] reported
increased mortality in African children (median age
24 months) with sepsis who received fluid boluses in
addition to maintenance fluids (2.5–4 mL/kg/h). Harmful
effects of fluid boluses were mainly observed in children
with compensated shock and profound anemia. More than
half of the children had malaria, a state where microcir-
culatory dysfunction is common due to sequestration of
parasitized erythrocytes rather than frank hypovolemia.
Widespread lack of intensive care facilities among study
centers may have contributed to harmful effects of
aggressive fluid loading.
Based on these data, patients with sepsis and tissue
hypoperfusion appear to benefit from a rapid bolus of
intravenous crystalloid solution of at least 20 mL/kg.
Further fluid resuscitation should be guided by the
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response to fluid loading. A positive response to fluid
loading can be considered as one of the following:[10%
increase of systolic/mean arterial blood pressure, [10%
reduction of heart rate, and/or improvement of mental
state, peripheral perfusion and/or urine output. Some adult
patients may require several liters of fluids during the first
24–48 h to achieve this goal. Likewise, fluid amounts as
high as 110 mL/kg may be required in children with
septic shock during early resuscitation [28]. In children
with profound anemia and severe sepsis, particularly due
to malaria, fluid boluses must only be administered cau-
tiously, and blood transfusion should be considered
instead [27].
Fluid resuscitation should be stopped or interrupted
when no improvement of tissue perfusion occurs in
response to volume loading. Development of crepitations
in adults plus hepatomegaly in children indicate fluid
overload or impaired cardiac function. Since aggressive
fluid resuscitation can lead to respiratory impairment,
additional fluid resuscitation following the initial fluid
boluses should be performed carefully if no mechanical
ventilator is available. In such a scenario, it may be
necessary to balance adequate pulmonary gas exchange
against optimum intravascular filling. However, this is an
infrequent conundrum within the first 6 h.
Fluid administration in septic patients should occur
intravenously even if access needs to be attained by
surgical cut-down or central venous cannulation. Alter-
natively, an intra-osseous access may be used. An intra-
osseous cannula should only be used if running freely and
for \24 h. Although oral rehydration is efficient to treat
dehydration [29], no data on the efficacy and safety of oral
Table 1 Definition of infection and sepsis syndromes
Suggested sepsis diagnosis with limited resources Sepsis diagnosis according to international consensus (22,
23)
Sepsis Proven or highly suspected infection plus presence
of C2 of the following conditions:
Proven or highly suspected infection plus presence of C2 of
the following conditions:
Heart rate [90 bpm Heart rate [90 bpm
Respiratory rate [20 bpm Respiratory rate [20 bpm or PaCO2 \32 mmHg
Temperature \36 or [38C Temperature \36 or [38C
Malaise and/or apathy WBC \4 or 12 g/L or [10% immature forms
Severe
sepsis
Sepsis-induced tissue hypoperfusion or organ dysfunction Sepsis-induced tissue hypoperfusion or organ dysfunction
Tissue hypoperfusion Tissue hypoperfusion
Decreased capillary refill or skin mottling Decreased capillary refill or skin mottling
Peripheral cyanosis Hyperlactatemia ([1 mmol/L)
Arterial hypotension Arterial hypotension
Systolic arterial blood pressure \90 mmHg or a systolic
arterial blood pressure decrease [40 mmHg
Systolic arterial blood pressure \90 mmHg; mean arterial
blood pressure \70 mmHg; or a systolic arterial blood
pressure decrease [40 mmHg
Pulmonary dysfunction Pulmonary dysfunction
SpO2 \90% with or without oxygen PaO2/FiO2 \300
Central cyanosis
Signs of respiratory distress (e.g., dyspnea, wheezing,
crepitations, unability to talk sentences)
Renal dysfunction Renal dysfunction
Acute oliguria (urine output \0.5 mL/kg/h or 45 mL/h
for at least 2 h despite adequate fluid resuscitation)
Acute oliguria (urine output\0.5 mL/kg/h or 45 mL/h for at
least 2 h despite adequate fluid resuscitation)
Creati nine increase [0.5 mg/dL or 44.2 lmol/L
Hepatic dysfunction Hepatic dysfunction
Jaundice Hyperbilirubinemia (plasma total bilirubin [4 mg/dL or
70 lmol/L
Coagulation dysfunction Coagulation dysfunction
Petechiae or ecchymoses Thrombocytopenia (platelet count, \100,000/lL)
Bleeding/oozing from puncture sites Coagulation abnormalities (INR [1.5 or a PTT [60 s)
Gastrointestinal dysfunction Gastrointestinal dysfunction
Ileus (absent bowel sounds) Ileus (absent bowel sounds)
Septic shock Sepsis-induced arterial hypotension despite adequate fluid
resuscitation (note that patients on inotropics or
vasopressors may not be hypotensive despite of presence
of shock) and signs of tissue hypoperfusion
Sepsis-induced arterial hypotension despite adequate fluid
resuscitation (note that patients on inotropics or
vasopressors may not be hypotensive despite of presence
of shock) and signs of tissue hypoperfusion
PaCO2 partial arterial carbon dioxide tension, WBC white blood
cell count, SpO2 plethysmographic oxygen saturation, PaO2/FiO2
partial arterial oxygen tension/fractional inspiratory oxygen
concentration quotient, INR international normalized ratio, PTT
partial thromboplastin time
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Table 2 General considerations for sepsis care
Timing Diagnose sepsis as early as possible (LoE: D)
Initiate sepsis treatment as early as possible (LoE: B). Antimicrobials should be given within 1 h of
recognizing sepsis (LoE: C). Hemodynamic endpoints should be achieved within 6 h of recognizing sepsis
(LoE: C)
Hygienic precautions Wash hands before and after each patient contact and whenever contaminated (LoE: B). Prefer alcohol rubs,
otherwise use running water and soap
Use sterile barrier precautions when performing invasive procedures or surgical interventions (LoE: A)
Patient monitoring Never leave the septic patient alone. Ensure continuous observation (LoE: D)
Perform clinical examinations several times per day (LoE: D)
Whenever available use a continuous patient monitor and set meaningful alarm limits (1D). Alarms for
children should be set at age appropriate ranges (LoE: D)
Multidisciplinary care Whenever applicable, seek consultation from experienced health care workers of other medical specialties
(LoE: D)
Data documentation Keep a patient record and document vital signs at meaningful intervals (LoE: D)
If the patient deteriorates or fails to improve look for the cause and seek medical review (LoE: D)
Convey essential information to all team members involved in the care of the septic patient (LoE: C)
Emergency drugs and
equipment
Keep an emergency supply of drugs and equipment on the ward that is available 24 h/day and is checked and
replenished daily (LoE: D)
Patient transfer Transfer of septi c patients to hospitals with more resources and/or medical expertise may save lives.
However, the risks must always be critically weighed against benefits (LoE: D)
Whenever possible transfer should be attended by a physician or other experienced medical personnel
(LoE: D)
Estimating prognosis and For each patient, critically assess the prognosis and extent of treatment (LoE: D)
Treatment limitation Limit treatment in adult patients with grave prognosis (LoE: D). Whenever possible make decisions together
with other colleagues and compassionately communicate it to the patient and family
Quality control Whenever possible and compatible with local culture, perform autopsies in patients who died from sepsis.
Communicate autopsy results to all team members and critically discuss points that could have been done
better (LoE: D)
Identify local strengths and weaknesses in sepsis management by documenting key aspects of sepsis care and
outcome (LoE: D)
LoE level of evidence
Table 3 Acute interventions to treat septic patients with limited resources
Circulation Use adequate tissue perfusion as the principal endpoint of resuscitation (LoE: A). In addition, target a systolic arterial
blood pressure[90 mmHg in adults, as well as normal heart rate and arterial blood pressure in children (LoE: 2D)
In patients with tissue hypoperfusion, infuse fluids aggressively and continue liberal infusions for 24–48 h (LoE: C).
More than 4 L during the first 24 h may be required to adequately resuscitate the adult septic patient
Use crystalloids and/or colloids for fluid resuscitation (LoE: B). When available, use colloid solutions for fluid
resuscitation in children with severe Dengue shock syndrome (LoE: B)
Use dopamine or epinephrine (adrenaline) in patients with persistent tissue hypoperfusion despite liberal fluid
resuscitation (LoE: C)
In patients requiring dopamine or epinephrine (adrenaline) measure arterial blood pressure and heart rate frequently
(LoE: D)
Administer intravenous hydrocortisone (up to 300 mg/day) or prednisolone (up to 75 mg/day) to adult patients
requiring escalating dosages of epinephrine (adrenaline) or dopamine (LoE: B). Consider the use of equivalent
hydrocortisone or prednisolone doses in children with severe shock (LoE: C)
Ventilation Apply oxygen to achieve an oxygen saturation[90% (LoE: B). If no pulse oximeter is available administer oxygen
empirically in patients with severe sepsis or septic shock (LoE: C)
Place patients in a semi-recumbent position (head of the bed raised to 30–45) (LoE: C)
Unconscious patients should be placed in the lateral position. The patient’s airway should be kept clear (LoE: D)
If available and medical staff is adequately trained, use non-invasive ventilation in patients with dyspnea and/or
persistent hypoxemia despite oxygen therapy (LoE: C)
Antimicrobial
therapy
Initiate sepsis treatment as early as possible (LoE: B). Antimicrobials should be given within 1 h of recognizing
sepsis (LoE: C)
Administer intravenous antimicrobials at adequate dosages and with a high likelihood to be active against the
suspected bacterial pathogens (LoE: C)
Diagnosis Perform a detailed patient history and thorough clinical examination to identify the source of infection (LoE: D). Use
imaging techniques when available (LoE: D)
Whenever possible and without harm to the patient, sample fluid or tissue from the site of infection (LoE: C)
Examine the sampled fluid or tissue by Gram stain, culture and whenever possible by antibiogram (LoE: C)
Source control Whenever possible drain or debride the source of infection (LoE: C)
Remove any foreign body or device that may potentially be the source of infection (LoE: C)
LoE level of evidence
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Fig. 1 Flowchart and summary of recommendations
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rehydration in septic patients with tissue hypoperfusion
exist. Considering a relevant aspiration risk, oral rehydra-
tion should be avoided in septic shock patients.
3. Use crystalloids and/or colloids for fluid resuscitation
(LoE: B). When available, use colloid solutions in
children with severe Dengue shock syndrome
(LoE: B).
Background There are no data supporting the superi-
ority of colloid over crystalloid solutions for resuscitation
of adults or children with bacterial sepsis [28, 30, 31]. In
most situations, adequacy of fluid resuscitation is more
relevant than the type of fluid infused. Considering high
costs [32], the risk of allergies [33] and potential renal and
coagulatory side effects [34] of colloids, crystalloid
solutions appear more suitable in resource-limited set-
tings. However, colloids may bear potential benefits in
children with severe Dengue shock syndrome (pulse
pressure B10 mmHg) [25]. In moderate Dengue shock
syndrome (pulse pressure [10 and B20 mmHg) colloid
and crystalloid solutions lead to similar outcomes. Since
moderate Dengue shock syndrome is more common than
severe, crystalloids remain the first-line fluid in the
majority of cases [25, 31].
4. Use dopamine or epinephrine (adrenaline) in patients
with persistent tissue hypoperfusion despite liberal
fluid resuscitation (LoE: C).
Background If fluid resuscitation cannot restore tissue
perfusion, the use of dopamine or epinephrine (adrena-
line) should be considered. While cool extremities,
extended neck veins, crepitations or crackles, a third or
fourth heart sound, and/or a positive hepato-jugular reflux
characterize the patient with impaired heart function,
patients with excessive peripheral vasodilation typically
present with warm extremities, oliguria and impaired
mental state. In many cases, however, it is difficult to
differentiate between the two states without measuring
cardiac output. Arrhythmogenic and obstructive causes of
fluid-resistant tissue hypoperfusion (e.g., pneumothorax,
pericardial tamponade, abdominal compartment syndrome)
must be excluded.
Studies suggest that neither dopamine nor epinephrine
is inferior to a balanced infusion of norepinephrine
(noradrenaline) and dobutamine with respect to septic
shock outcome [35–37]. Considering frequent aggrava-
tion of lactic acidosis during epinephrine infusion [38],
norepinephrine should, whenever available, be preferred
over epinephrine. Since all catecholamines typically exert
dose-dependent adverse side effects, doses should be kept
at a minimum. Although dopamine-refractory shock may
be reversed with epinephrine or norepinephrine infusion
in children [39], combined use of dopamine and epi-
nephrine is discouraged.
Preferentially, dopamine or epinephrine is infused
through a central venous catheter. If central venous
catheters are unavailable or the medical staff has insuf-
ficient experience handling them [40], a peripheral venous
cannula, placed in a large bore vein, or an intra-osseous
cannula can be used. It is important to frequently check
the site of infusion for signs of drug extravasation, since
substantial skin necrosis may occur [41]. Dopamine and
epinephrine should be administered continuously. When
pumps are unavailable or power cuts frequently occur,
dopamine (e.g., 250 mg) or epinephrine (e.g., 5–10 mg)
can be diluted in 500 mL of crystalloid solution and
infused using a drop regulator or micro-infusion set.
Dosing should occur based on the clinical response.
5. In patients requiring dopamine or epinephrine (adren-
aline) measure arterial blood pressure and heart rate
frequently (LoE: D).
Background In children and adults requiring dopamine
or epinephrine (adrenaline), blood pressure should be
measured frequently [6, 7, 11]. The invasive technique is
rarely available in resource-limited settings and requires
specific training. Alternatively, blood pressure can be
measured non-invasively. Specifically in children, ade-
quately sized cuffs must be used to ensure accurate
readings. Intervals for non-invasive blood pressure mea-
surements should be set at 5–15 min as long as
epinephrine or dopamine is infused.
6. Administer intravenous hydrocortisone (up to 300 mg/
day) or prednisolone (up to 75 mg/day) to adult
patients requiring escalating dosages of epinephrine
(adrenaline) or dopamine (LoE: B). Consider the use
of equivalent hydrocortisone or prednisolone doses in
children with severe shock (LoE: C).
Background Relative adrenal insufficiency with inad-
equately low plasma cortisol levels is frequent in septic
shock [42]. If hydrocortisone is administered to adults
requiring escalating catecholamine doses in high-income
settings, shock duration and mortality are reduced [42,
43]. An Indian randomized pilot study suggested a trend
towards earlier shock reversal and less inotrope use when
Table 4 Clinical indicators of adequate tissue hypoperfusion
Normal capillary refill timea
Absence of skin mottling
Warm and dry extremities
Well felt peripheral pulses (e.g., radial or dorsalis pedis pulses)
Return to baseline mental status before sepsis onset
Urine output [0.5 (adults) or 1 (children) mL/kg/hourb
a Age dependent: children and adults (\65 years), \2–3 s;
elderly patients ([65 years) \4.5 s
b Unless elevated creatinine plasma levels or sign of established
renal failure
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hydrocortisone (5 mg/kg/day in four divided doses fol-
lowed by half the dose for a total of 7 days) was
administered to children with septic shock [44]. Until
more data are available, use of hydrocortisone must be
considered a rescue therapy in pediatric septic shock.
Daily corticosteroid dosages must not exceed equivalent
doses of 300 mg hydrocortisone or 75 mg prednisolone,
since higher doses may predispose for infections [45].
Corticosteroids should not be administered to patients not
requiring catecholamines unless they are on chronic cor-
ticosteroid therapy. When epinephrine or dopamine can
be withdrawn, corticosteroids should be tapered off (over
days) to avoid rebound hypotension [42].
Ventilation
1. Apply oxygen to achieve an oxygen saturation [90%
(LoE: B). If no pulse oximeter is available administer
oxygen empirically in patients with severe sepsis or
septic shock (LoE: D).
Background Apart from tissue hypoperfusion, organ
dysfunction associated with sepsis arises from hypoxemia
[46], which is highly prevalent in resource-limited set-
tings [47]. Clinical signs (e.g., cyanosis) are not reliable,
particularly in patients with dark complexion. Clinical
signs of respiratory distress (dyspnea, increased work of
breathing) reflect changes in respiratory mechanics and
may not be reliable gauges of hypoxemia. Therefore, it is
essential to monitor septic patients with a pulse oximeter
[48, 49]. Patients presenting with hypoxemia should
receive oxygen to achieve an oxygen saturation[90%. In
Papua New Guinea, installation of hospital wide oxygen
systems facilitated oxygen therapy for hypoxemic chil-
dren with pneumonia and reduced the risk of death [50]. If
no pulse oximeter is available, oxygen should empirically
be administered to all septic patients (see Electronic
Supplementary Material for technical details).
2. Place patients in a semi-recumbent position (head of
the bed raised to 30–45) (LoE: C).
Background Unless hemodynamically unstable, septic
patients should be placed in a semi-recumbent position
(head of the bed raised to 30–45). Semi-recumbency
reduces the risk of tracheal aspiration and hospital-
acquired pneumonia, particularly when mental state is
impaired or enteral nutrition administered [51, 52].
3. Unconscious patients should be placed in the lateral
position. The patient’s airway should be kept clear
(LoE: C).
Background Unconscious patients and subjects who
cannot keep their airway open for other reasons should be
placed in the lateral position. In addition, an oro- or
nasopharyngeal airway can be inserted if the lateral
position alone cannot maintain airway patency. Inability
to clear the airway is associated with a high risk for
aspiration of saliva or regurgitated gastric contents. Oral
hygiene (tooth brushing and cleansing with an oral anti-
septic at least twice daily), repetitive suctioning of
oropharyngeal secretions and placement in the semi-
recumbent position (also the lateral position) can prevent
pneumonia [53].
4. If available and medical staff is adequately trained, use
non-invasive ventilation in patients with dyspnea and/
or persistent hypoxemia despite oxygen therapy (LoE:
C).
Background Sepsis may lead to deterioration of lung
function. In severe cases, respiratory insufficiency may
not be sufficiently treated by oxygen alone, even when
administered at high flow rates. Wherever available and
when medical staff is adequately trained, mechanical
ventilation should be instituted early in patients with
increased work of breathing and/or persistent hypoxemia
despite oxygen therapy. In many resource-limited settings,
non-invasive mechanical ventilation (administration of
ventilatory support through a mask instead of an endo-
tracheal tube or tracheostoma) appears to be the
ventilation technique of choice [54]. Non-invasive ventila-
tion has been applied with good success in patients with
acute respiratory failure in Pakistan [55]. Data from India
reported that non-invasive intermittent positive pressure
ventilation decreased the need for endotracheal intubation in
acute respiratory failure of diverse origin [56]. Nasal con-
tinuous positive airway pressure improved the management
of respiratory insufficient children with Dengue hemorrhagic
fever in Southeast Asia [57]. Despite these positive reports,
studies performed in high-income settings demonstrate that
not all patients can successfully be managed with non-
invasive ventilation [54]. This is specifically true for septic
patients with impaired consciousness, severe respiratory or
cardiovascular failure. Particularly young children may
not tolerate non-invasive ventilation. Furthermore, airway
anatomy (large tongue, short neck) combined with the need
for lower tidal volumes makes non-invasive ventilation in
children difficult [58].
If equipment is available and medical staff adequately
trained, mechanical ventilation may be delivered via an
endotracheal tube. When doing so an adequate level of
positive end-expiratory pressure with tidal volumes of
6 mL/kg ideal body weight should be set [59, 60]. Fur-
thermore, peak (pressure control ventilation mode) or
plateau (volume control ventilation mode) pressures
should not exceed 30 cmH2O [61]. Spontaneous breath-
ing modes are equally preferred in intubated patients [62].
If mechanical ventilators are unavailable, anesthetic cir-
cuits or machines may be used to ventilate a patient with
respiratory distress or during the postoperative period.
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Antimicrobial therapy
1. Initiate sepsis treatment as early as possible (LoE: B).
Antimicrobials should be given within 1 h of recog-
nizing sepsis (LoE: C).
Background Robust evidence indicates that timely
diagnosis of sepsis and rapid initiation of treatment
reduces morbidity and mortality both in children and
adults [63–68]. In a high-income country, each hour of
delay in antibiotic administration was associated with an
average 7.6% decrease in survival of septic shock [66].
Similarly, in a predominantly HIV-infected septic patient
population in Uganda, any delay in the administration of
adequate antibiotics increased all cause and attributable
mortality [23]. Likewise, pre-referral administration of
rectal artesunate reduced death in severe malaria in rural
Asia and Africa [69].
2. Administer intravenous antimicrobials at adequate
dosages and with a high likelihood to be active against
the suspected bacterial pathogens (LoE: C).
Background Intravenous antimicrobial therapy is one
of the key treatments in septic patients. If intravenous
access cannot be promptly attained in children, first
antimicrobial dosages may be administered intra-muscu-
larly or by the oral or rectal route. Two factors critically
determine the benefit of antimicrobial therapy both in
resource-rich [66–68] and resource-limited settings [22]:
timing and adequacy. Since the causative pathogen cannot
be identified immediately, antimicrobial therapy must be
started empirically. To ensure that empirical antimicrobial
therapy is active against the causative microorganisms, it
is vital to account for the likely pathogen spectrum. In
middle- and low-income settings, this is particularly
challenging since the range of infectious diseases and
causative microorganisms is broad, including bacterial,
viral, fungal and parasitic pathogens [23]. Further diffi-
culties arise from frequent antimicrobial resistance [70],
common preceeding self-medication with over-the-coun-
ter antibiotics [71, 72] and the limited availability of
potent intravenous antimicrobials [12–15]. Considerable
regional heterogeneities in these aspects make recom-
mendation of empirical antimicrobial strategies difficult.
In a multicenter study performed in middle- and low-
income countries, chloramphenicol was superior to
injectable ampicillin plus gentamicin in the treatment of
community-acquired severe pneumonia in children aged
2-59 months [73]. To optimize chances of appropriate
empirical antimicrobial therapy, empiric antimicrobial
therapy should be adjusted to local infectious disease
patterns including HIV/AIDS prevalence, pathogen
spectrum and antimicrobial resistance.
Adequate dosing is another important aspect of anti-
microbial therapy. Considering the high risk of death
associated with sepsis, antimicrobial drugs need to be
administered at maximum recommended dosages during
the initial phase [74]. This is of particular importance if
antimicrobials of unclear quality (e.g., counterfeit or
expired drugs) are used. Following the acute phase, many
antibiotics require dose adjustments to renal or hepatic
function. To achieve optimum bioavailability, the intra-
venous route is preferred. When the patient improves,
antimicrobials may be administered orally provided that
intestinal absorption is maintained.
Diagnosis
1. Perform a detailed patient history and thorough clini-
cal examination to identify the source of infection
(LoE: D). Use imaging techniques when available
(LoE: D).
Background Following first resuscitation steps and
initiation of empirical antimicrobial therapy, it is critical
to identify the source of infection. A thorough patient
history and clinical investigation are essential to do so.
Although imaging techniques (e.g., X-ray, ultrasound)
may be used to answer specific diagnostic questions,
nothing can replace a thorough medical history and sys-
tematic head-to-toe examination.
2. Whenever possible and without harm to the
patient, sample fluid or tissue from the site of infection
(LoE: C).
Background Microbiological identification of the
causative microorganism of sepsis is useful to confirm
presence the diagnosis and allows for targeted antimi-
crobial therapy. For microbiological cultures, blood, fluid
or tissue from the suspected site of infection needs to be
sampled in a sterile fashion [75]. Whenever clinically
justifiable and timely achievable this should be done
before initiation of empirical antimicrobial therapy to
maximize the sensitivity of microbiological cultures. If
microbiological cultures are unavailable, it may still be
rational to collect samples for visual or microscopic
analysis.
3. Examine the sampled fluid or tissue by Gram stain,
culture and whenever possible for antibiotic suscepti-
bility (LoE: C).
Background After samples have been obtained,
transport to the microbiological laboratory should take
place as fast as possible. Gram staining and microscopic
examination should be performed whenever applicable.
Also in resource-limited areas, microbiological cultures
remain the gold standard to cultivate microbes. When
microorganisms grow, susceptibility to locally available
antibiotics should be assessed allowing for targeted anti-
microbial therapy. Where parasitic infections are endemic
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or suspected specific laboratory tests should be used (e.g.,
thick smear analysis for diagnosis of malaria). Rapid
communication of positive microbiological test results to
the clinician in charge is imperative.
Source control
1. Whenever possible drain or debride the source of
infection (LoE: C).
Background Along with timely and adequate antimi-
crobial therapy, source control is the only causative
therapy of sepsis. As soon as basic resuscitation measures
and empiric anti-infective therapy have been instituted,
source control measures must be prioritized. Source
control measures should be timed depending on several
factors such as the patient’s condition, surgical expertise
and resource availability. In invasive Staphylococcus
aureus infection, source control reduced mortality in a
provincial hospital in northeast Thailand [76]. Typical
infectious sources requiring emergent source control
measures are abscesses (except for pulmonary abscesses),
necrotizing soft tissue and wound infections, gastroin-
testinal perforation, cholangitis, obstructive urinary tract
infection, and any deep space infection such as pleural
empyema or septic arthritis. Depending on local avail-
ability of experts and resources, the least invasive
technique should be chosen (e.g., percutaneous/endo-
scopic instead of surgical abscess drainage). Not all
infectious sources are amenable to surgical source control
(e.g., pneumonia, meningitis). In these patients, timing
and adequacy of antimicrobial therapy remain the key
component of sepsis care.
2. Remove any foreign body or device that may poten-
tially be the source of infection (LoE: C).
Background Device-related infections are particularly
frequent in intensive care units of middle- and low-
income countries [77, 78]. Any artificial device (e.g.,
venous catheter) should carefully be checked for signs of
infection. When signs of infection are present, removal of
the device represents the key treatment. Infectious signs
are frequently insensitive to diagnose infections arising
from artificial devices, since infection of internal parts of
the device may not cause cutaneous reactions. Therefore,
removal of artificial devices should be considered if
device-related infection is suspected. Before explanting
permanent intravascular (e.g., implanted central venous
access) or surgically introduced devices (e.g., hip or knee
prosthesis, cardiac pacemaker), other sources of infection
need to be safely excluded.
Post-acute interventions
Post-acute interventions (Table 5) may be postponed until
the patient has been resuscitated but should be instituted
within 24 h of recognizing sepsis.
Antimicrobial therapy
1. Reassess the effectiveness of the antimicrobial regi-
men regularly (LoE: C).
Background Regular assessment of the patient’s
response to source control and antimicrobial therapy is
essential to promptly recognize inadequate source control.
Although no clear time limit has been defined, worsening
or ongoing organ dysfunction and persistence of infec-
tious signs (e.g., fever) for more than 48 to 72 h following
initiation of treatment should question the adequacy of
sepsis therapy. Common causes of treatment failure are
summarized in Table 6. Aside from situations when the
patient’s condition worsens or fails to improve, empirical
antimicrobial therapy should be re-assessed after micro-
biological results are available. Antimicrobial therapy
needs adjustment to pathogen susceptibility. De-escala-
tion of antimicrobial therapy reduces the likelihood of
bacterial selection and induction of resistance [79]. If
Table 5 Post-acute interventions to treat septic patients with limited resources
Antimicrobial
therapy
Reassess the effectiveness of the antimicrobial regimen regularly (LoE: C)
Administer antimicrobials for an adequate but not prolonged time (LoE: D)
Glucose control Whenever possible check blood sugar levels in every septic patient (LoE: D)
Aim to keep blood glucose[70 mg/dL ([4 mmol/L) by providing a glucose calorie source (LoE: B). Do not target
upper blood glucose levels \150 mg/dL (\8.3 mmol/L) (LoE: D)
DVT prophylaxis Use prophylactic heparin and/or apply elastic bandages on both legs in post-pubertal children and adults (LoE: A).
No deep vein thrombosis prophylaxis is required in pre-pubertal children
Enteral nutrition Allow the patient to eat and drink small amounts once she/he is fully resuscitated and awake (LoE: C)
Sedation and pain
relief
Use opioids to relieve pain. Titrate opioids cautiously in unstable patients (LoE: D)
Only sedate the agitated and uncooperative patient (LoE: D)
As soon as the patient is stable encourage mobilization (LoE: A)
Wean invasive
support
As soon as the patient is improving, try to actively wean the extent of invasive support (LoE: D)
LoE level of evidence, DVT deep venous thrombosis
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microbiological cultures remain negative, it is critical to
discern whether infection is present but pathogens were
not cultivated or a non-infectious disease is present. The
sensitivity of microbiological cultures depends on the
sampled specimen and is far from 100%, even in high-
income countries [75]. Sensitivities of microbiological
cultures in resource-limited settings must be assumed to
be even lower due to a widespread lack of appropriate
inoculation and culture media [80].
2. Administer antimicrobials for an adequate but not
prolonged time (LoE: D).
Background The aim of antimicrobial therapy is to
administer an adequate anti-infective agent long enough
to eradicate causative microbes and short enough to pre-
vent super-infection with microorganisms selected during
antimicrobial therapy. Unnecessary antimicrobial therapy,
administered for presumed safety reasons, poses a sig-
nificant threat [81]. The length of antimicrobial treatment
must individually be determined based on the type of
pathogen cultivated, site of infection, adequacy of source
control, treatment response, presence of artificial devices
and immune status.
Glucose control
1. Whenever possible check blood sugar levels in every
septic patient (LoE: D).
Background Disturbances of glucose homeostasis
often occur in sepsis [82, 83]. Hypoglycemia was
observed in 16.3% of Ugandan patients with sepsis on
hospital admission. Hypoglycemia was independently
associated with in-hospital mortality. Altered mental state
at admission revealed a specificity of 86% to predict
hypoglycemia in septic patients [83]. Certain infectious
diseases (e.g., malaria) are associated with an increased
risk of hypoglycemia, particularly in children and patients
with limited glycogen stores (e.g., malnourished patients or
subjects with liver disease) [84]. Considering detrimental
effects of even short periods of hypoglycemia [85], blood
sugar levels should be measured as early as possible,
especially in patients with impaired mental state. If it is not
possible to check blood sugar in a patient with impaired
mental state at hospital admission, a presumptive diagnosis
of hypoglycemia should be made and intravenous glucose
administered.
2. Aim to keep blood glucose [70 mg/dL ([4 mmol/L)
by providing a glucose calorie source (LoE: B). Do not
target upper blood glucose levels \150 mg/dL
(\8.3 mmol/L) (LoE: D).
Background Given the harmful effects of hypoglyce-
mia [85], patients without hyperglycemia should receive
an oral/enteral or intravenous glucose calorie source
to prevent hypoglycemia. In patients presenting with
low blood sugar, 30–50 g of glucose must urgently be
administered.
Tight glucose control [targeting an upper glucose limit
\150 mg/dL (\8.3 mmol/L)] is associated with an
increased risk of hypoglycemic events, morbidity and
mortality in sepsis and critical illness [34, 85]. In resource-
limited settings, further aspects (e.g., limited availability of
resources to measure blood glucose) increase the risk of
hypoglycemia when targeting a tight glucose level range.
Based on this, we discourage from targeting upper blood
glucose levels \150 mg/dL (\8.3 mmol/L).
Deep vein thrombosis prophylaxis
1. Use prophylactic heparin and/or apply elastic bandages
on both legs in adults and post-pubertal children (LoE:
A). No deep vein thrombosis prophylaxis is required in
pre-pubertal children (LoE: A).
Background Although in many resource-limited set-
tings the prevalence of deep venous thrombosis has been
assumed to be too low to justify widespread antithrom-
botic prophylaxis [86], more recent data point at relevant
morbidity and mortality associated with deep venous
thrombosis also in middle- and low-income countries [87,
88]. In a post mortem analysis of 989 Nigerian patients,
sepsis and immobility[4 days were predisposing factors
for venous thromboembolism [89]. Routine thromboem-
bolism prophylaxis should be administered to all post-
pubertal septic patients who have no increased bleeding
risk or ongoing hemorrhage [90]. In settings where no
heparin is available, either antithrombotic stockings or
elastic bandages can be applied [91].
Enteral nutrition
1. Allow the patient to eat and drink small amounts once
she/he is fully resuscitated and awake (LoE: C).
Table 6 Common causes for treatment failure in sepsis in
resource-poor settings
Inadequate empirical anti-infective therapya
Missed or insufficient control of the infectious focus
Insufficient supportive therapy (suboptimal fluid resuscitation)
Development of new antimicrobial resistance
Occurence of a new, hospital-acquired infection
Clinical symptoms are due to other diseases than sepsis
a Common reasons for inadequate empirical anti-infective
therapy are: wrong group of pathogen targeted (e.g., bacterial
instead of protozoic pathogen), administration of antimicrobial
with a too narrow spectrum, primary resistance of the pathogen
against antimicrobial therapy, use of counterfeit or expired
drugs
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Background Sepsis disrupts the integrity of the
gastrointestinal mucosal barrier and exposes the patient
to an increased risk of gastric ulcer formation, partic-
ularly when shock, hypoxemia, coagulopathy and
corticosteroid therapy are present [92]. Breakdown of
the intestinal mucosal barrier can lead to persistent
stimulation of the immune system and translocation of
bacteria or bacterial components into the bloodstream
[93]. Early administration of small amounts of fluids or
enteral nutrition through a nasogastric tube improves
gastrointestinal mucosal integrity and outcome in high-
income settings [94]. At the same time, early enteral
nutrition decreases the risk of gastric ulcer formation
and upper gastrointestinal hemorrhage [94]. However,
early enteral nutrition is not without risks and may
cause gastrointestinal ischemia when administered
to patients in shock [95]. Particularly in middle- and
low-income countries where patients rarely have their
airway protected, early enteral nutrition may predispose
to gastric regurgitation and pulmonary aspiration
[unpublished data, Arjen Dondorp]. Therefore, enteral
nutrition should be administered as early as possible,
but only after the patient has adequately been resusci-
tated and is fully awake. In intubated patients, enteral
nutrition (e.g., milk supplemented by cooking oil, salt,
sugar, soya and a multivitamin tablet) through a naso-
gastric tube should be initiated after hemodynamic
function has stabilized.
Table 7 Suggested therapies to be avoided in the septic patient (level of evidence: D)
Background
DO NOT use hypotonic fluids (e.g., glucose solutions) for fluid
resuscitation
Hypotonic fluids only have a little effect on intravascular volume
status but carry a high risk of tissue edema, brain edema and
dyselectrolytemia
DO NOT use fluid balance as a guide to administer or withhold
further volume loading
Fluid resuscitation should always be indicated by the patient’s
condition and the individual response to fluid loading. Significant
under-resuscitation may occur
DO NOT use high dose steroids (e.g., hydrocortisone[300 mg/day
or prednisolone [75 mg/day)
High dose steroids do not change mortality but relevantly increase
the risk of hospital-acquired infection, hyperglycemia,
gastrointestinal bleeding and/or delirium. Note relevant
exceptionsa
DO NOT use muscle relaxants except for endotracheal intubation
and in mechanically ventilated patients with severe respiratory
distress
Muscle relaxants increase the risk of neuromuscular weakness and
prolonged paralysis from sepsis
DO NOT use succinylcholine in patients immbolized [3 days or
with neuromuscular diseases
Succinylcholine may cause hyperkalemia resistant to treatment
when administered to patients immbolized [3 days or with
neuromuscular diseases
DO NOT use furosemide unless hypervolemia, hyperkalemia and/or
renal acidosis are/is present
Furosemide cannot improve kidney function but may even be
harmful to the kidney. Treat the patient and not the urine output!
DO NOT use dopamine in an attempt to improve renal function Dopamine cannot prevent renal failure in sepsis but may even cause
adverse side effects
DO NOT use sodium bicarbonate to treat metabolic acidosis arising
from tissue hypoperfusion
Effectiveness of sodium bicarbonate to correct metabolic acidosis is
unsure. Although a marker of disease severity, acidosis may have
protective effects
DO NOT use non-steroidal anti-inflammatory analgesics Non-steroidal anti-inflammatory analgesics cannot improve sepsis
outcome but may impair renal and coagulation function as well as
increase the risk of stress ulcer formation
DO NOT restrict oxygen because of considerations to reduce
respiratory drive
Only few patients with chronic obstructive pulmonary disease have
their respiratory drive suppressed by oxygen. The risk of
accepting hypoxia in the majority of patients is unacceptably
higher than the risk of inducing hypoventilation in a few
DO NOT diagnose ‘‘fever of unknown origin’’ ‘‘Fever of unknown origin’’ is a diagnosis by exclusion. Resource
limitations usually do not allow for full work-up of patients to
make this diagnosis. Always assume and treat infection in the
patient in whom fever cannot be explained by other pathologies
DO NOT use insulin if blood sugar cannot be measured regularly If blood sugar is not measured regularly liberal insulin use may
result in hypoglycemia with devastating neurological results.
Depending on the availability of blood sugar tests adjust the
upper glucose limit. If blood sugar can be measured several times
a day the optimum blood sugar range would be 70–180 mg/dL
(4–10 mmol/L)
aIndications for steroids in infectious diseases (Lit mervyn CC 2006):
meningitis (dexamethasone 4 9 10 mg/day for 48 h, optimally com-
mence before first antibiotic dose, does not seem to be effective in
Asian patients), severe pneumocystis jiroveci pneumonia with hyp-
oxemia (prednisolone 2 9 40 mg/day for 5 days ? 1 9 40 mg/day
for 5 days ? 1 9 20 mg for 10 days), tuberculous meningitis (dexa-
methasone 0.3–0.4 mg/kg/d tapered over 4 weeks), tuberculous
pericarditis (prednisolone 60 mg tapered over 11 weeks), and
onchocerciasis (prednisolone 60 mg for 3 days)
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Sedation and pain relief
1. Use opioids to relieve pain. Titrate opioids cautiously
in unstable patients (LoE: D).
Background Opioids are potent analgesics and useful
in patients suffering pain. Particularly in unstable patients,
they may cause adverse effects (respiratory depression,
hypotension, bradycardia, alteration of mental state) and
must be used cautiously. This is of particular importance
when facilities to secure the airway and provide
mechanical ventilation are limited. Opioids should only
be administered at diluted concentrations by the intrave-
nous route. Intramuscular injections of large depot
dosages may result in unpredictable effects. Septic shock
patients typically require lower opioid dosages than
hemodynamically stable patients [96]. If opioids are
administered a ventilation bag and opioid antagonist
should readily be available to treat unexpected respiratory
depression.
2. Only sedate the agitated and uncooperative patient
(LoE: D).
Background Similar to opioids, sedatives can reduce
ventilatory drive, increase the risk of pulmonary aspira-
tion, impair hemodynamic function and alter mental state.
Therefore, sedatives should only be administered to agi-
tated and uncooperative patients who cannot be managed
by other means. In cases where symptoms of acute
delirium prevail, neuroleptic drugs (e.g., haloperidol) are
preferred over benzodiazepines [97]. Like opioids, all
sedative agents need to be titrated to the patient’s
response, and emergency equipment be held available.
Encourage family members to participate in care to calm
the patient.
3. As soon as the patient is stable encourage mobilization
(LoE: A).
Background Prolonged bed rest causes numerous
unwanted effects, including muscular atrophy, prolonged
weakness, respiratory compromise, autonomic dysfunc-
tion, hypovolemia, gastrointestinal paralysis, deep venous
thrombosis, and delirium [98]. Early mobilization may
prevent or counteract these effects and hasten recovery
[99].
Wean invasive support
1. As soon as the patient is improving, try to actively
wean invasive support (LoE: D).
Background Every therapy carries risk of adverse
effects and may potentially harm. Therapies that are
commonly administered and are associated with a high
risk of adverse events are invasive procedures [77, 78],
use of catecholamines [100], steroids [101] and sedative/
opioid agents [102]. Therapies whose risks outweigh their
assumed benefits and should be avoided based on the
authors’ expert opinion are listed in Table 7. Therefore, it
is crucial to actively reduce invasive support as soon as
the patient has stabilized. Active but careful reduction of
Table 8 Management of sepsis due to specific causes
Malaria Prompt start of parenteral artesunate in adults and children (2.4 mg/kg STAT followed by the same dose at
12 h, 24 h, and then daily until oral medication can be taken) (LoE: A)
If injectable artesunate is unavailable intramuscular artemether (3.2 mg/kg on admission followed by
1.6 mg/kg daily), artesunate by suppositories (8–16 mg/kg at 0 and 12 h and then daily) or intravenous
quinine (20 mg/kg loading dose over 4 h followed by 10 mg/kg over 4 h 8 hourly until oral medication is
possible) can be used (LoE: A)
In children, parenteral antibiotics should be given in addition to antimalarial treatment (LoE: A)
Parenteral antibiotics should be given to adults with slide proven malaria and who present with a clinical
syndrome requiring parenteral antibiotics (meningitis/encephalopathy, malnutrition, very severe or
severe pneumonia) (LoE: A)
Seizures should be treated with rectal or intravenous diazepam, intravenous lorazepam, paraldehyde or
other standard anticonvulsants (LoE: B)
In the absence of shock, fluid management should be performed judiciously and more restrictively than in
patients with bacterial sepsis (LoE: B)
In case of severe anemia (e.g., hemoglobin level\6 g/dL), blood transfusion should be considered (LoE: A)
Empirical antibiotic therapy needs to cover Gram-positive, Gram-negative and anaerobic bacteria (LoE: B)
Puerperal sepsis Treatment of tuberculosis infection in resource-limited settings is best performed by timely initiation of the
combination of isoniazid, rifampicin, pyrazinamide and ethambutol for 2 months followed by isoniazid
and rifampicin alone for another 4 months (LoE: A)
Septic patients with
HIV/AIDS
Patients with open mycobaterial infections require isolation/cohorting (LoE: A)
In Pneumocystis jiroveci pneumonia, the therapy of choice is trimethoprim/sulfamethoxazole administered
for 3 weeks. In patients with hypoxemia, prednisolone (40 mg bid for 5 days followed by 40 mg/day for
5 days and then 20 mg/day for 11 days) should be added (LoE: B)
In malnourished patients, energy supply should be re-started slowly with a stepwise increase of daily caloric
intake and avoidance of large amounts of carbohydrates to prevent the re-feeding syndrome (LoE: B)
LoE level of evidence
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therapeutic intensity can reduce length of hospital stay
and prevent complications. A prospective study from
Thailand revealed that reminding physicians to remove
unnecessary urinary catheters reduced the rate of catheter-
associated urinary infections [103].
Specific considerations for sepsis management
Specific considerations for the management of septic
patients with malaria, puerperal sepsis or HIV/AIDS are
summarized in Table 8 and detailed in the Electronic
Supplementary Material.
Implementing current recommendations into clinical
practice
Effective implementation of guidelines into clinical
practice is challenging. Summarizing different recom-
mendations in care bundles has been shown to facilitate
implementation of the Surviving Sepsis Campaign guide-
lines [8, 9]. Accordingly, we suggest two care bundles in
order to implement the presented recommendations on
sepsis management in resource-poor settings (Table 9).
Although it is yet unclear which guideline implementation
strategy is most likely to be efficient [104], several
approaches have been successfully applied. Common single
interventions include reminders, dissemination of educa-
tional materials, audits and feedback. Multifaceted
approaches typically involve daily application of checklists,
educational outreach, a multidisciplinary approach, as well
as a conceptual framework [104]. Dissemination of mobile
phone text message reminders to health care workers in
Kenya resulted in a sustained improvement of adherence to
pediatric malaria guidelines [105].
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